RUA Life Sciences (LON:RUA) Releases Earnings Results

RUA Life Sciences (LON:RUA) announced its quarterly earnings data on Tuesday. The company reported GBX (0.33) earnings per share for the quarter, Digital Look Earnings reports. RUA Life Sciences had a negative return on equity of 2.03% and a negative net margin of 3.26%.

RUA Life Sciences Trading Up 4.7%

Shares of LON RUA traded up GBX 0.90 during mid-day trading on Friday, hitting GBX 19.90. The stock had a trading volume of 94,275 shares, compared to its average volume of 239,239. The company has a debt-to-equity ratio of 18.95, a quick ratio of 7.32 and a current ratio of 4.64. The firm has a market cap of £12.35 million, a P/E ratio of -2.61 and a beta of 0.96. RUA Life Sciences has a 1 year low of GBX 10.42 and a 1 year high of GBX 26.80. The business has a 50 day moving average price of GBX 19.96 and a two-hundred day moving average price of GBX 16.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.